(S (NP-SBJ-13 (NP (NN Inhibition)) (PP (IN of) (NP (ADJP (NN phorbol) (JJ ester-induced)) (JJ monocytic) (NN differentiation))) (PP (IN by) (NP (NN dexamethasone)))) (VP (VBZ is) (VP (VBN associated) (NP (-NONE- *-13)) (PP (IN with) (NP (NP (NN down-regulation)) (PP (IN of) (NP (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-)))))))) (. .))
(S (NP-SBJ (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ-14 (NP (NN treatment)) (PP (IN of) (NP (JJ human) (JJ myeloid) (NN leukemia) (NNS cells))) (PP (IN with) (NP (NP (NN 12-O-tetradecanoylphorbol-13-acetate)) (PRN (-LRB- -LRB-) (NP (NN TPA)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN associated) (NP (-NONE- *-14)) (PP (IN with) (NP (NP (NN induction)) (PP (IN of) (NP (NP (JJ monocytic) (NP-COOD (NP (NN differentiation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos))) (JJ early) (NN response) (NNS genes))))))))))))) (. .))
(S (NP-SBJ (DT The) (JJ present) (NN work)) (VP (VBZ demonstrates) (SBAR (IN that) (S (NP-SBJ (DT the) (NN glucocorticoid) (NN dexamethasone)) (VP (VBZ inhibits) (NP (NP (JJ TPA-induced) (NNS increases)) (PP (IN in) (NP (NP (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos))) (NN mRNA) (NNS levels)) (PP (IN in) (NP (NN U-937) (NN leukemia) (NNS cells)))))))))) (. .))
(S (NP-SBJ-15 (DT These) (NNS findings)) (VP (VBD were) (VP (VBN associated) (NP (-NONE- *-15)) (PP (IN with) (NP (NP (DT a) (NN block)) (PP (IN in) (NP (NP (NN appearance)) (PP (IN of) (NP (DT the) (JJ monocytic) (NN phenotype))))) (, ,) (PP (VBG including) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (JJ TPA-induced) (NNS increases)) (PP (IN in) (NP (NP (NN lamin) (NN A)) (, ,) (NP (NN lamin) (NN C)) (, ,) (CC and) (NP (NN vimentin) (NNS transcripts)))))))))))) (. .))
(S (NP-SBJ (JJ Other) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP-SBJ-17 (NP (JJ TPA-induced) (JJ monocytic) (NP-COOD (NP (NN differentiation)) (CC and) (NP (NN expression)))) (PP (IN of) (NP (NP (DT the) (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos))) (NNS genes)) (PP (IN in) (NP (JJ myeloid) (NN leukemia) (NNS cells)))))) (VP (VBP are) (VP (VBN regulated) (NP (-NONE- *-17)) (PP (IN by) (NP-LGS (NP (NN protein) (NN kinase) (NN C)) (PRN (-LRB- -LRB-) (NP (NN PKC)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ (DT The) (NN finding) (SBAR (IN that) (S (NP-SBJ (NN dexamethasone)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (JJ TPA-induced) (NN activation)) (PP (IN of) (NP (NN PKC))))))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (DT this) (NN glucocorticoid)) (VP (VBZ inhibits) (NP (NP (NNS signals)) (ADJP (ADJP-COOD (ADJP (JJ downstream) (PP (-NONE- *RNR*-18))) (CC or) (ADJP (JJ parallel) (PP (-NONE- *RNR*-18)))) (PP-18 (TO to) (NP (DT this) (NN enzyme))))))))) (. .))
(S (NP-SBJ (JJ Nuclear) (JJ run-on) (NNS assays)) (VP (VBP demonstrate) (SBAR (IN that) (: :) (S-COOD (S (LST (-LRB- -LRB-) (LS 1) (-RRB- -RRB-)) (NP-SBJ-19 (NP (NN induction)) (PP (IN of) (NP (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos))) (NN expression))) (PP (IN by) (NP (NN TPA)))) (VP (VBZ is) (VP (VBN regulated) (NP (-NONE- *-19)) (PP (IN by) (NP-LGS (JJ transcriptional) (NNS mechanisms)))))) (, ,) (S (LST (-LRB- -LRB-) (LS 2) (-RRB- -RRB-)) (NP-SBJ (NP (JJ TPA-induced) (NN expression)) (PP (IN of) (NP-COOD (NP (NN c-jun)) (CC and) (NP (NN c-fos))))) (VP (VBZ does) (RB not) (VP (VB require) (NP (NN protein) (NN synthesis))))) (, ,) (CC and) (S (LST (-LRB- -LRB-) (LS 3) (-RRB- -RRB-)) (NP-SBJ-20 (NP (JJ TPA-induced) (NN expression)) (PP (IN of) (NP (DT both) (NNS genes)))) (VP (VBZ is) (VP (VBN inhibited) (NP (-NONE- *-20)) (PP (IN at) (NP (DT the) (JJ transcriptional) (NN level))) (PP (IN by) (NP-LGS (NN dexamethasone))))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *-21)) (VP (TO To) (ADVP (RB further)) (VP (VB define) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN dexamethasone))) (PP (IN at) (NP (DT the) (JJ molecular) (NN level))))))) (, ,) (NP-SBJ-21 (PRP we)) (VP (VBD prepared) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (VBN deleted) (NN c-jun) (NN promoter) (NNS fragments)) (VP (VBN linked) (NP (-NONE- *)) (PP (TO to) (NP (DT the) (NP (NP (NN chloramphenicol) (NN acetyltransferase)) (PRN (-LRB- -LRB-) (NP (NN CAT)) (-RRB- -RRB-))) (NN gene)))))))) (. .))
(S (NP-SBJ-22 (NP (NNS Increases)) (PP (IN in) (NP (NP (NN CAT) (NN activity)) (PP-TMP (IN during) (NP (NP (JJ transient) (NN expression)) (PP (IN of) (NP (NP (DT these) (NNS constructs)) (PP (IN in) (NP (JJ TPA-treated) (NN U-937) (NNS cells)))))))))) (VP (MD could) (VP (VB be) (VP (VBN assigned) (NP (-NONE- *-22)) (PP (TO to) (NP (NP (NP (DT the) (NN region)) (PRN (-LRB- -LRB-) (NP-COOD (NP (CD -97)) (TO to) (NP (CD -20))) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN promoter))) (SBAR (WHNP-24 (WDT that)) (S (NP-SBJ (-NONE- *T*-24)) (VP (VBZ contains) (NP (DT the) (NN AP-1) (NN binding) (NN site)))))))))) (. .))
(S (NP-SBJ (NP (DT This) (NN induction)) (PP (IN of) (NP (NN CAT) (NN activity)))) (VP (VBD was) (ADJP-PRD (JJ sensitive) (PP (TO to) (NP (NN dexamethasone))))) (. .))
(S (NP-SBJ (DT These) (NNS findings)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-25 (NN dexamethasone)) (VP (VBZ down-regulates) (NP (NP (JJ TPA-induced) (NN transcription)) (PP (IN of) (NP (DT the) (NN c-jun) (NN gene)))) (PP-TMP (IN during) (NP (JJ monocytic) (NN differentiation))) (PP (IN by) (S (NP-SBJ (-NONE- *-25)) (VP (VBG inhibiting) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN AP-1) (NN site))))))))))) (. .))
